GNE-477, a novel dual inhibitor of PI3K/mTOR, has been demonstrated to inhibit the growth of renal cell carcinoma cells in vitro and in vivo (Ye et al., 2020). This evidence concerns the gene MTOR and renal cell carcinoma.